Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
212
relevant articles (6 outcomes,
10 trials/studies)
found for this Disease
Description:
Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990)
Also Known As:
Subcorneal Pustular Dermatosis; Skin Diseases, Vesiculobullous; Bullous Dermatoses; Vesiculobullous Dermatoses; Bullous Skin Disease; Dermatoses, Bullous; Dermatoses, Subcorneal Pustular; Dermatoses, Vesiculobullous; Dermatosis, Subcorneal Pustular; Pustular Dermatoses, Subcorneal; Skin Disease, Bullous; Skin Disease, Vesicular; Skin Disease, Vesiculobullous; Sneddon Wilkinson Disease; Subcorneal Pustular Dermatoses; Vesicular Skin Disease; Vesiculobullous Skin Disease; Bullous Skin Diseases; Pustular Dermatosis, Subcorneal; Skin Diseases, Bullous; Skin Diseases, Vesicular; Sneddon-Wilkinson Disease; Vesicular Skin Diseases
Relationship Network
Disease Context: Research Results
Related Diseases
Experts
| 1. | Zillikens, Detlef:
2 articles
(05/2008 - 04/2007)
|
| 2. | Hertl, M:
2 articles
(12/2001 - 09/2001)
|
| 3. | Hashimoto, T:
2 articles
(11/2000 - 07/2000)
|
| 4. | Pfütze, Martin:
1 article
(05/2008)
|
| 5. | Rose, Christian:
1 article
(05/2008)
|
| 6. | Niedermeier, Andrea:
1 article
(05/2008)
|
| 7. | Karlhofer, Franz:
1 article
(05/2008)
|
| 8. | Hunzelmann, Nicolas:
1 article
(05/2008)
|
| 9. | Reiser, Marcel:
1 article
(05/2008)
|
| 10. | Nitschke, Martin:
1 article
(05/2008)
|
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Vesiculobullous Skin Diseases:
| 1. | Immunoglobulin A (IgA)IBA
|
| 2. | AutoantibodiesIBA
|
| 3. | DapsoneFDA Link
|
| 4. | infliximab (Remicade)FDA Link
11/01/2005
- " Early but not lasting improvement of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease) after infliximab therapy: relationships with variations in cytokine levels in suction blister fluids." 03/01/2004
- " RESULTS: Infliximab has been used in the following dermatological diseases: psoriasis, Behcet's disease, graft versus host disease, hidradenitis suppurativa, panniculitis, pyoderma gangrenosum, SAPHO (synovitis, acne, pustulosis, hyperostosis and osteitis) syndrome, sarcoidosis, subcorneal pustular dermatosis, Sweet's syndrome, toxic epidermal necrolysis, and Wegener's granulomatosis" 12/01/2001
- " Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease)."
Order ALL the reference details at left...
|
| 5. | Cyclosporine (Ciclosporin)FDA LinkGeneric
|
| 6. | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
|
| 7. | Prednisolone (Predate)FDA LinkGeneric
|
| 8. | Arachidonic Acid (Vitamin F)IBA
|
| 9. | mebhydroline (mebhydrolin)IBA
|
| 10. | Proteins (Proteins, Gene)IBA
|
|
Therapies and Procedures